Tumor Biology

, Volume 34, Issue 4, pp 2249–2254 | Cite as

RETRACTED ARTICLE: XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese

Research Article


The X-ray repair cross-complementing group 3 (XRCC3) gene has been suggested to play an important role in the pathogenesis of hepatocellular carcinoma (HCC). However, the results have been inconsistent. In this study, we performed a meta-analysis to clarify the association of XRCC3 Thr241Met variant with HCC. The published literature from PubMed, Chinese National Knowledge Infrastructure, and Wan Fang data was retrieved. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed or random effects model. A total of five studies (1,531 HCC cancer cases and 1,952 controls) for XRCC3 Thr241Met variant were included in the meta-analysis. The meta-analysis showed that XRCC3 Thr241Met variant was associated with HCC risk under homogeneous codominant model (OR = 3.99, 95 % CI = 1.74–9.13) and recessive model (OR = 5.22, 95 % CI = 3.65–7.48), but not under heterogeneous codominant model (OR = 1.18, 95 % CI = 0.68–2.05) and dominant model (OR = 1.37, 95 % CI = 0.73–2.57). Subgroup analysis by ethnicity suggested that XRCC3 Thr241Met variant was associated with HCC risk in Chinese population, but not in Pakistani population. The present meta-analysis supported the positive association of XRCC3 Thr241Met variant with HCC in the Chinese. Further large-scale studies with the consideration for gene–gene/gene–environment interactions should be conducted to investigate the association.


XRCC3 Polymorphism Hepatocellular carcinoma Meta-analysis 



The work was funded by Zhejiang Medicine, Health, and Science (no. 2010KYB127), Zhejiang Province Chinese Medicine Research Program (2012ZA130), and Zhejiang Gong Yi Xing Technology Application Project (2012C33025).

Conflicts of interest



  1. 1.
    Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120:194–202.CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  3. 3.
    Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874–97.CrossRefPubMedGoogle Scholar
  4. 4.
    Miller MC, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett. 2001;120:269–80.CrossRefPubMedGoogle Scholar
  5. 5.
    Zipprich J, Terry MB, Brandt-Rauf P, Freyer GA, Liao Y, Agrawal M, et al. XRCC1 polymorphisms and breast cancer risk from the New York site of the Breast Cancer Family Registry: a family-based case–control study. J Carcinog. 2010;9:4.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Xu L. Association between polymorphism of DNA repair genes and hepatocellular carcinoma susceptibility: a case–control study. Master's dissertation of Fudan University; 2003. 1–42. Chinese.Google Scholar
  7. 7.
    Long XD, Ma Y, de Qu Y, Liu YG, Huang ZQ, Huang YZ, et al. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China. Ann Epidemiol. 2008;18:572–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Liu W. The relation between genetic polymorphism of DNA repair gene XRCC3, XRCC4 and susceptibility to primary hepatocellular carcinoma. Master's dissertation of Fujian Medical University. 1–56. Chinese.Google Scholar
  9. 9.
    Han X, Xing Q, Li Y, Sun J, Ji H, Huazheng P, Jun L. Study on the DNA repair genes XRCC1 and XRCC3 polymorphisms in prediction and prognosis of hepatocellular carcinoma risk. Hepatogastroenterology. 2012;59 (119): doi: 10.5754/hge12096.
  10. 10.
    Zeng X, Liu S, Yu H, Ji L, Li L, Huang J, et al. DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China. DNA Cell Biol. 2012;31:1384–91.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gulnaz A, Sayyed AH, Amin F, Khan A, Aslam MA, Shaikh RS, et al. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus. Eur J Gastroenterol Hepatol. 2013;25:166–79.CrossRefPubMedGoogle Scholar
  12. 12.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMedGoogle Scholar
  13. 13.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  14. 14.
    Long XD, Ma Y, Deng ZL, Huang YZ, Wei NB. Association of the Thr241Met polymorphism of DNA repair gene XRCC3 with genetic susceptibility to AFB1-related hepatocellular carcinoma in Guangxi population. Chin J Med Genet. 2008;25:268–71. Chinese.Google Scholar
  15. 15.
    Xu YH, Gu LP, Sun YJ, Cheng BJ, Lu S. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2013;34(2):865–74.CrossRefPubMedGoogle Scholar
  16. 16.
    Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case–control studies. Mol Biol Rep. 2012. doi: 10.1007/s11033-012-2471-5.
  17. 17.
    Yin QH, Liu C, Li L, Zu XY, Wang YJ. Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case–control studies. Asian Pac J Cancer Prev. 2012;13:5201–5.CrossRefPubMedGoogle Scholar
  18. 18.
    He XF, Wei W, Su J, Yang ZX, Liu Y, Zhang Y, et al. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case–control studies. Mol Biol Rep. 2012;39:5125–34.CrossRefPubMedGoogle Scholar
  19. 19.
    Li F, Li C, Jiang Z, Ma N, Gao X. XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology. 2011;77:511.e1–5.PubMedGoogle Scholar
  20. 20.
    Fang F, Wang J, Yao L, Yu XJ, Yu L, Yu L. Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis. Med Oncol. 2011;28:999–1003.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of Clinical LaboratoryTaizhou Municipal HospitalTaizhouChina
  2. 2.Department of OrthopedicsTaizhou Municipal HospitalTaizhouChina

Personalised recommendations